StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Established Markets by Quarter

Established Markets ($M)

QuarterlyAnnual

Novartis Established Markets: $10,739M in Q3 2026, up 2.4% from a year earlier.

Latest, Q3 2026
10,739
Period ended Sep 30, 2026
Change on a year earlier
+2.4%
10,489 in Q3 2025
History
30 quarters
Since Q2 2019
Sources
26
Documents cited below

Where the Q3 2026 figure comes from

“|| Of which in established markets | 10 739 | 10 489 | 2 | 3 | 74 | 75”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEstablished Markets ($M)Year on yearSource
Q3 2026Sep 30, 202610,739+2.4%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 202610,5360.0%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 20269,262-4.2%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 20259,860-3.4%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 202510,489+10.3%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 202510,537+15.0%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2025Mar 31, 20259,669+13.9%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 202410,209+18.0%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 20249,512+9.1%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 20249,162+8.3%Novartis Form 6-K (0001370368-25-000012) ↗
Q1 2024Mar 31, 20248,488+7.5%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2023Dec 31, 20238,655+8.4%Novartis Form 6-K (0001370368-25-000007) ↗
Q3 2023Sep 30, 20238,719+12.8%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2023Jun 30, 20238,456-54.2%Novartis Form 6-K (0001370368-24-000019) ↗
Q1 2023Mar 31, 20237,895-13.7%Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2022Dec 31, 20227,985-79.2%Novartis Form 6-K (0001370368-24-000007) ↗

Breakdown

What makes up established Markets

Cite this data

StockData. (2026). Novartis Established Markets ($M), quarterly Q2 2019–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/geo-established-markets

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.